CorMedix CRMD
NASDAQ CRMD
$5.36 -0.11 (-1.92%)
As of: Nov 10, 2026 · 3:36 PM EST

CorMedix (CRMD) Current Leases (2025)

Updated

CorMedix (CRMD) recorded Current Leases of $596,000 in Q4 2025, up 2.9% from the prior quarter.

Analysis

CorMedix (CRMD) Current Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 CorMedix 438.89 Mn -201.00 Mn 77.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 596,000.00
Sep 30, 2025 579,168.00
API Access

CorMedix Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CRMD&period=max&api_key=YOUR_API_KEY